Department of Immunotechnology
41 – 50 of 1021
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Fine tuning of the innate and adaptive immune responses by Interleukin-2
- Contribution to journal › Article
-
Mark
Linear epitopes of bony fish β-parvalbumins
- Contribution to journal › Article
-
Mark
Empowering macrophages : the cancer fighters within the tumour microenvironment in mantle cell lymphoma
- Contribution to journal › Article
-
Mark
Predictive and Prognostic Biomarkers in Patients With Mycosis Fungoides and Sézary Syndrome (BIO-MUSE) : Protocol for a Translational Study
- Contribution to journal › Article
-
Mark
The hinge-engineered IgG1-IgG3 hybrid subclass IgGh47 potently enhances Fc-mediated function of anti-streptococcal and SARS-CoV-2 antibodies
- Contribution to journal › Article
-
Mark
Automated multiplexed affinity-based enrichment of peptides for LC-MS/MS plasma proteomics
- Contribution to journal › Article
-
Mark
CD163+ macrophages in mantle cell lymphoma induce activation of prosurvival pathways and immune suppression
- Contribution to journal › Article
-
Mark
Enhancing cell death in B-cell malignancies through targeted inhibition of Bcl-3
- Contribution to journal › Article
-
Mark
The role of dendritic cells in tertiary lymphoid structures: implications in cancer and autoimmune diseases : Mariana Reste1† , Kristi Ajazi 2† , Ayca Sayi-Yazgan3,4, Radmila Jankovic 5 , Biljana Bufan6 , Sven Brandau7 , Espen S. Bækkevold 8 , Florent Petitprez 9 , Malin Lindstedt 2 *, Gosse J. Adema10* and Catarina R. Almeida1 *
- Contribution to journal › Article
-
Mark
Combining CD40 agonist mitazalimab with mFOLFIRINOX in previously untreated metastatic pancreatic ductal adenocarcinoma (OPTIMIZE-1) : a single-arm, multicentre phase 1b/2 study
- Contribution to journal › Article
